SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-002472
Filing Date
2023-11-14
Accepted
2023-11-14 16:06:51
Documents
65
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q seel-20230930x10q.htm   iXBRL 10-Q 2145785
2 EX-31.1 seel-20230930xex31d1.htm EX-31.1 14410
3 EX-31.2 seel-20230930xex31d2.htm EX-31.2 13834
4 EX-32.1 seel-20230930xex32d1.htm EX-32.1 7596
5 EX-32.2 seel-20230930xex32d2.htm EX-32.2 7581
6 GRAPHIC seel-20230930x10q001.jpg GRAPHIC 27991
7 GRAPHIC seel-20230930x10q003.jpg GRAPHIC 41504
  Complete submission text file 0001410578-23-002472.txt   8686047

Data Files

Seq Description Document Type Size
8 EX-101.SCH seel-20230930.xsd EX-101.SCH 59930
9 EX-101.CAL seel-20230930_cal.xml EX-101.CAL 40979
10 EX-101.DEF seel-20230930_def.xml EX-101.DEF 243999
11 EX-101.LAB seel-20230930_lab.xml EX-101.LAB 519132
12 EX-101.PRE seel-20230930_pre.xml EX-101.PRE 391072
59 EXTRACTED XBRL INSTANCE DOCUMENT seel-20230930x10q_htm.xml XML 1415864
Mailing Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 (646) 293-2100
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22245 | Film No.: 231406043
SIC: 2834 Pharmaceutical Preparations